Sonosensitive Cavitation Nuclei-A Customisable Platform Technology for Enhanced Therapeutic Delivery
Brian Lyons1, Joel P R Balkaran1, Darcy Dunn-Lawless1
1Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford OX1 3PJ, UK.
Molecules (Basel, Switzerland)
|December 9, 2023
Summary
Cavitation nuclei enhance ultrasound drug delivery. These sound-sensitive constructs offer a versatile platform for targeted therapeutics, showing promise for clinical translation.
Area of Science:
- Biomedical Engineering
- Acoustic Medicine
- Drug Delivery Systems
Background:
- Ultrasound-mediated cavitation is a promising technique for targeted drug delivery.
- Cavitation nuclei, sound-sensitive constructs, amplify cavitation at lower pressures.
- These nuclei are emerging as independent drug delivery vehicles.
Purpose of the Study:
- To review the structure, function, and applications of cavitation nuclei in drug delivery.
- To explore methods for functionalizing and customizing cavitation nuclei.
- To discuss progress and future directions in the clinical translation of this technology.
Main Methods:
- Review of existing literature on cavitation nuclei and ultrasound-mediated drug delivery.
- Analysis of the physical, biological, and chemical effects associated with cavitation nuclei.
- Examination of various compositions, morphologies, and functionalization strategies.
Main Results:
- Cavitation nuclei offer a tunable platform for drug delivery due to their unique properties.
- Functionalization allows for customization of these nuclei for specific therapeutic needs.
- Significant progress has been made toward real-world translation of ultrasound-based therapies.
Conclusions:
- Cavitation nuclei represent a versatile and effective platform for ultrasound-mediated targeted drug delivery.
- Further research into functionalization and clinical applications will drive therapeutic advancements.
- The field is poised for significant growth and translation into clinical practice.
Related Concept Videos
01:19Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also called...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...